Divis Laboratories

Divi’s Laboratories rises on reporting 92% rise in Q3 consolidated net profit

by

Divi’s Laboratories is currently trading at Rs. 4334.10, up by 20.70 points or 0.48% from its previous closing of Rs. 4313.40 on the BSE.

Divis Laboratories
Divis Laboratories

The scrip opened at Rs. 4300.55 and has touched a high and low of Rs. 4475.00 and Rs. 4240.60 respectively.

The BSE group ‘A’ stock of face value Rs. 10 has touched a 52 week high of Rs. 5,425.00 on 18-Oct-2021 and a 52 week low of Rs. 3,154.50 on 19-March-2021. Divi’s Laboratories

Last one week high and low of the scrip stood at Rs. 4475.00 and Rs. 4164.95 respectively. The current market cap of the company is Rs. 1,15,056.74 crore.

You Can Also Read This  Gayatri Highways shines on completing acquisition of 51% stake in Balaji Highways Holding

Divi’s Laboratories has reported a rise of 96.69% in its net profit at Rs 907.22 crore for the quarter ended December 31, 2021 as compared to Rs 461.24 crore for the same quarter in the previous year. Total income of the company increased by 48.16% at Rs 2,483.39 crore for Q3FY22 as compared Rs 1,676.16 crore for the corresponding quarter previous year.

You Can Also Read This  NMDC trades in green on the bourses

On the consolidated basis, the company has reported a rise of 91.71% in its net profit at Rs 902.24 crore for the quarter ended December 31, 2021 as compared to Rs 470.62 crore for the same quarter in the previous year. Total income of the company increased by 45.86% at Rs 2,509.86 crore for Q3FY22 as compared Rs 1,720.76 crore for the corresponding quarter previous year.